Przegląd Dermatologiczny (Oct 2020)

Risankizumab as an effective therapeutic option in severe psoriasis unsuccessfully treated with therapies involving anti- TNF-α and anti-IL-17

  • Michał Adamczyk,
  • Dorota Krasowska

DOI
https://doi.org/10.5114/dr.2020.99882
Journal volume & issue
Vol. 107, no. 4
pp. 385 – 392

Abstract

Read online

No abstracts available.

Keywords